Review



fbs plus recombinant clusterin  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems fbs plus recombinant clusterin
    <t>Recombinant</t> <t>clusterin</t> protects human beta cells against thapsigargin-induced apoptosis. EndoC-βH1 cells were pretreated for 24 h with 0 (white bars), 1 (grey bars) or 100 ng/ml (purple bars) recombinant clusterin. Medium was then changed, and cells were exposed or not to clusterin and thapsigargin (THAP, 1 μmol/l). Apoptosis ( a ) and DP5 expression ( b ) were analysed after 48 h. Gene expression was corrected for the geometric mean of the reference genes ACTB and VAPA and normalised to the condition THAP without clusterin set as 1. Results are mean ± SEM of six independent experiments. ** p <0.01 and *** p <0.001 compared with no clusterin/non-treated (NT); †† p <0.01 and ††† p <0.001 compared with no clusterin/THAP (ANOVA)
    Fbs Plus Recombinant Clusterin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fbs+plus+recombinant+clusterin/Recombinant+Human+Clusterin+Protein%2C+CF/pmc09676790-98-12-18
    Average 94 stars, based on 18 article reviews
    fbs plus recombinant clusterin - by Bioz Stars, 2026-10
    94/100 stars

    Images

    1) Product Images from "Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes"

    Article Title: Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes

    Journal: Diabetologia

    doi: 10.1007/s00125-022-05837-9

    Recombinant clusterin protects human beta cells against thapsigargin-induced apoptosis. EndoC-βH1 cells were pretreated for 24 h with 0 (white bars), 1 (grey bars) or 100 ng/ml (purple bars) recombinant clusterin. Medium was then changed, and cells were exposed or not to clusterin and thapsigargin (THAP, 1 μmol/l). Apoptosis ( a ) and DP5 expression ( b ) were analysed after 48 h. Gene expression was corrected for the geometric mean of the reference genes ACTB and VAPA and normalised to the condition THAP without clusterin set as 1. Results are mean ± SEM of six independent experiments. ** p <0.01 and *** p <0.001 compared with no clusterin/non-treated (NT); †† p <0.01 and ††† p <0.001 compared with no clusterin/THAP (ANOVA)
    Figure Legend Snippet: Recombinant clusterin protects human beta cells against thapsigargin-induced apoptosis. EndoC-βH1 cells were pretreated for 24 h with 0 (white bars), 1 (grey bars) or 100 ng/ml (purple bars) recombinant clusterin. Medium was then changed, and cells were exposed or not to clusterin and thapsigargin (THAP, 1 μmol/l). Apoptosis ( a ) and DP5 expression ( b ) were analysed after 48 h. Gene expression was corrected for the geometric mean of the reference genes ACTB and VAPA and normalised to the condition THAP without clusterin set as 1. Results are mean ± SEM of six independent experiments. ** p <0.01 and *** p <0.001 compared with no clusterin/non-treated (NT); †† p <0.01 and ††† p <0.001 compared with no clusterin/THAP (ANOVA)

    Techniques Used: Recombinant, Expressing, Gene Expression

    Related Articles

    Recombinant:

    Article Title: Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes
    Article Snippet: .. EndoC-βH1 cells were pre-cultured for 24 h in medium supplemented with 2% FBS plus recombinant clusterin (no. 2937-HS-050, R&D Systems, Minneapolis, MN, USA) at concentrations of 1 and 100 ng/ml. ..



    Similar Products

    fbs plus recombinant clusterin  (R&D Systems)
    94
    R&D Systems fbs plus recombinant clusterin
    <t>Recombinant</t> <t>clusterin</t> protects human beta cells against thapsigargin-induced apoptosis. EndoC-βH1 cells were pretreated for 24 h with 0 (white bars), 1 (grey bars) or 100 ng/ml (purple bars) recombinant clusterin. Medium was then changed, and cells were exposed or not to clusterin and thapsigargin (THAP, 1 μmol/l). Apoptosis ( a ) and DP5 expression ( b ) were analysed after 48 h. Gene expression was corrected for the geometric mean of the reference genes ACTB and VAPA and normalised to the condition THAP without clusterin set as 1. Results are mean ± SEM of six independent experiments. ** p <0.01 and *** p <0.001 compared with no clusterin/non-treated (NT); †† p <0.01 and ††† p <0.001 compared with no clusterin/THAP (ANOVA)
    Fbs Plus Recombinant Clusterin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fbs+plus+recombinant+clusterin/Recombinant+Human+Clusterin+Protein%2C+CF/pmc09676790-98-12-18
    Average 94 stars, based on 1 article reviews
    fbs plus recombinant clusterin - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Recombinant clusterin protects human beta cells against thapsigargin-induced apoptosis. EndoC-βH1 cells were pretreated for 24 h with 0 (white bars), 1 (grey bars) or 100 ng/ml (purple bars) recombinant clusterin. Medium was then changed, and cells were exposed or not to clusterin and thapsigargin (THAP, 1 μmol/l). Apoptosis ( a ) and DP5 expression ( b ) were analysed after 48 h. Gene expression was corrected for the geometric mean of the reference genes ACTB and VAPA and normalised to the condition THAP without clusterin set as 1. Results are mean ± SEM of six independent experiments. ** p <0.01 and *** p <0.001 compared with no clusterin/non-treated (NT); †† p <0.01 and ††† p <0.001 compared with no clusterin/THAP (ANOVA)

    Journal: Diabetologia

    Article Title: Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes

    doi: 10.1007/s00125-022-05837-9

    Figure Lengend Snippet: Recombinant clusterin protects human beta cells against thapsigargin-induced apoptosis. EndoC-βH1 cells were pretreated for 24 h with 0 (white bars), 1 (grey bars) or 100 ng/ml (purple bars) recombinant clusterin. Medium was then changed, and cells were exposed or not to clusterin and thapsigargin (THAP, 1 μmol/l). Apoptosis ( a ) and DP5 expression ( b ) were analysed after 48 h. Gene expression was corrected for the geometric mean of the reference genes ACTB and VAPA and normalised to the condition THAP without clusterin set as 1. Results are mean ± SEM of six independent experiments. ** p <0.01 and *** p <0.001 compared with no clusterin/non-treated (NT); †† p <0.01 and ††† p <0.001 compared with no clusterin/THAP (ANOVA)

    Article Snippet: EndoC-βH1 cells were pre-cultured for 24 h in medium supplemented with 2% FBS plus recombinant clusterin (no. 2937-HS-050, R&D Systems, Minneapolis, MN, USA) at concentrations of 1 and 100 ng/ml.

    Techniques: Recombinant, Expressing, Gene Expression